Catalyst Wire Dossier Catalyst Wire Dossier

Restasis X

cyclosporine · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Restasis X, covering 2018-05-15 to 2018-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease [Phase 2]

See pricing